Thursday, September 13, 2012

UCF nanoscientist receives $2 million NIH award

UCF nanoscientist receives $2 million NIH award [ Back to EurekAlert! ] Public release date: 13-Sep-2012
[ | E-mail | Share Share ]

Contact: Zenaida Kotala
zenaida.kotala@ucf.edu
407-823-6120
University of Central Florida

The National Institutes of Health today awarded University of Central Florida Professor Ming Su its coveted New Innovator award, which comes with a $2 million grant.

The award recognizes visionary science that exhibits the potential to transform scientific fields and speed the translation of research into improved health, according to the NIH director's office. Su's research focuses on using nanoparticles to concentrate and precisely direct radiation energy to destroy cancerous tumors.

Su says nearly half of cancer patients receive radiation therapy at some point during treatment, but X-ray doses can damage normal tissue around the cancer. The idea of using nanoparticles to improve radiation therapy has been studied for the past several years as a way to enhance the potency of the cancer killing radiation, while limiting damage to surrounding healthy cells.

Because of the imprecise nature of radiation it is often used at lower dose than required, Su said. But that can lead to incomplete killing of cancer cells and recurrence of a tumor later.

Su will be using nanoparticles in way they have not been used before so that radiation energy will be deposited preferentially to tumors.

"By doing so, the total X-ray dose required to kill the tumor will be reduced, and the damage to normal tissues will be minimized," Su said.

The award is one of 10 Pioneer awards, 51 New Innovator awards, and 20 Transformative Research awards announced by the NIH today. The total funding is approximately $155 million.

Su, associate professor at UCF's NanoScience Technology Center, is the only researcher from a Florida university to be selected and only one of 82 recipients nationwide announced today

The program funding all the projects, the High Risk Reward program, supports a series of exceptionally high-impact research programs that are broadly relevant to health and disease.

"The Common Fund High Risk High Reward program provides opportunities for innovative investigators in any area of health research to take risks when the potential impact in biomedical and behavioral science is high," said NIH Director Dr. Francis S. Collins.

The New Innovator Award received by Su supports investigators who had received their Ph.D. or M.D. within the last ten years.

Last year Su received the National Science Foundation's prestigious early CAREER award for a project using phase change nanoparticles as thermal probes to detect multiple cancer biomarkers.

###

UCF Stands For Opportunity --The University of Central Florida is a metropolitan research university that ranks as the second largest in the nation with more than 59,000 students. UCF's first classes were offered in 1968. The university offers impressive academic and research environments that power the region's economic development. UCF's culture of opportunity is driven by our diversity, Orlando environment, history of entrepreneurship and our youth, relevance and energy. For more information visit http://news.ucf.edu



[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


UCF nanoscientist receives $2 million NIH award [ Back to EurekAlert! ] Public release date: 13-Sep-2012
[ | E-mail | Share Share ]

Contact: Zenaida Kotala
zenaida.kotala@ucf.edu
407-823-6120
University of Central Florida

The National Institutes of Health today awarded University of Central Florida Professor Ming Su its coveted New Innovator award, which comes with a $2 million grant.

The award recognizes visionary science that exhibits the potential to transform scientific fields and speed the translation of research into improved health, according to the NIH director's office. Su's research focuses on using nanoparticles to concentrate and precisely direct radiation energy to destroy cancerous tumors.

Su says nearly half of cancer patients receive radiation therapy at some point during treatment, but X-ray doses can damage normal tissue around the cancer. The idea of using nanoparticles to improve radiation therapy has been studied for the past several years as a way to enhance the potency of the cancer killing radiation, while limiting damage to surrounding healthy cells.

Because of the imprecise nature of radiation it is often used at lower dose than required, Su said. But that can lead to incomplete killing of cancer cells and recurrence of a tumor later.

Su will be using nanoparticles in way they have not been used before so that radiation energy will be deposited preferentially to tumors.

"By doing so, the total X-ray dose required to kill the tumor will be reduced, and the damage to normal tissues will be minimized," Su said.

The award is one of 10 Pioneer awards, 51 New Innovator awards, and 20 Transformative Research awards announced by the NIH today. The total funding is approximately $155 million.

Su, associate professor at UCF's NanoScience Technology Center, is the only researcher from a Florida university to be selected and only one of 82 recipients nationwide announced today

The program funding all the projects, the High Risk Reward program, supports a series of exceptionally high-impact research programs that are broadly relevant to health and disease.

"The Common Fund High Risk High Reward program provides opportunities for innovative investigators in any area of health research to take risks when the potential impact in biomedical and behavioral science is high," said NIH Director Dr. Francis S. Collins.

The New Innovator Award received by Su supports investigators who had received their Ph.D. or M.D. within the last ten years.

Last year Su received the National Science Foundation's prestigious early CAREER award for a project using phase change nanoparticles as thermal probes to detect multiple cancer biomarkers.

###

UCF Stands For Opportunity --The University of Central Florida is a metropolitan research university that ranks as the second largest in the nation with more than 59,000 students. UCF's first classes were offered in 1968. The university offers impressive academic and research environments that power the region's economic development. UCF's culture of opportunity is driven by our diversity, Orlando environment, history of entrepreneurship and our youth, relevance and energy. For more information visit http://news.ucf.edu



[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Source: http://www.eurekalert.org/pub_releases/2012-09/uocf-unr091312.php

west memphis three shaun white taxes game of thrones season 2 trailer sag award winners girl scout cookies screen actors guild

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.